Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.

Sun Y, Klose T, Liu Y, Modrow S, Rossmann MG.

J Virol. 2019 Apr 17;93(9). pii: e01732-18. doi: 10.1128/JVI.01732-18. Print 2019 May 1.

2.

Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study.

Würdinger M, Modrow S, Plentz A.

Viruses. 2017 Jun 13;9(6). pii: E149. doi: 10.3390/v9060149.

3.

Persistent pure red cell aplasia in dicygotic twins with persistent congenital parvovirus B19 infection-remission following high dose intravenous immunoglobulin.

Lejeune A, Cremer M, von Bernuth H, Edelmann A, Modrow S, Bührer C.

Eur J Pediatr. 2014 Dec;173(12):1723-6. doi: 10.1007/s00431-014-2420-5. Epub 2014 Oct 2.

PMID:
25269997
4.

Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.

Plentz A, Würdinger M, Kudlich M, Modrow S.

J Clin Virol. 2013 Oct;58(2):443-8. doi: 10.1016/j.jcv.2013.07.007. Epub 2013 Jul 31.

PMID:
23916377
5.

Seroepidemiology of human bocavirus in Apulia, Italy.

Guido M, Zizza A, Bredl S, Lindner J, De Donno A, Quattrocchi M, Grima P, Modrow S; Seroepidemiology Group.

Clin Microbiol Infect. 2012 Apr;18(4):E74-6. doi: 10.1111/j.1469-0691.2011.03756.x. Epub 2012 Feb 6.

6.

False-negative serology in patients with acute parvovirus B19 infection.

Bredl S, Plentz A, Wenzel JJ, Pfister H, Möst J, Modrow S.

J Clin Virol. 2011 Jun;51(2):115-20. doi: 10.1016/j.jcv.2011.03.012. Epub 2011 May 6.

PMID:
21530386
7.

Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.

Modrow S, Wenzel JJ, Schimanski S, Schwarzbeck J, Rothe U, Oldenburg J, Jilg W, Eis-Hübinger AM.

Vox Sang. 2011 May;100(4):351-8. doi: 10.1111/j.1423-0410.2010.01445.x. Epub 2010 Dec 7.

PMID:
21133933
8.

Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders.

Jitschin R, Peters O, Plentz A, Turowski P, Segerer H, Modrow S.

Clin Microbiol Infect. 2011 Sep;17(9):1336-42. doi: 10.1111/j.1469-0691.2010.03355.x. Epub 2011 Mar 3.

9.

Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.

Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S.

Clin Infect Dis. 2009 Dec 1;49(11):1660-6. doi: 10.1086/648074.

PMID:
19863443
10.

Prevalence and clinical aspects of human bocavirus infection in children.

Karalar L, Lindner J, Schimanski S, Kertai M, Segerer H, Modrow S.

Clin Microbiol Infect. 2010 Jun;16(6):633-9. doi: 10.1111/j.1469-0691.2009.02889.x. Epub 2009 Aug 4.

11.

Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis.

Pongratz G, Lindner J, Modrow S, Schimanski S, Schölmerich J, Fleck M.

J Intern Med. 2009 Sep;266(3):296-301. doi: 10.1111/j.1365-2796.2009.02117.x. Epub 2009 Apr 23.

12.

No detection of human bocavirus in amniotic fluid samples from fetuses with hydrops or isolated effusions.

Enders M, Lindner J, Wenzel JJ, Baisch C, Schalasta G, Enders G, Modrow S.

J Clin Virol. 2009 Aug;45(4):300-3. doi: 10.1016/j.jcv.2009.04.005. Epub 2009 May 26.

PMID:
19473872
13.

Humoral immune response against human bocavirus VP2 virus-like particles.

Lindner J, Karalar L, Zehentmeier S, Plentz A, Pfister H, Struff W, Kertai M, Segerer H, Modrow S.

Viral Immunol. 2008 Dec;21(4):443-9. doi: 10.1089/vim.2008.0045.

PMID:
19115933
14.

Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.

Herse F, Verlohren S, Wenzel K, Pape J, Muller DN, Modrow S, Wallukat G, Luft FC, Redman CW, Dechend R.

Hypertension. 2009 Feb;53(2):393-8. doi: 10.1161/HYPERTENSIONAHA.108.124115. Epub 2008 Dec 8.

PMID:
19064815
15.

Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.

Escher F, Modrow S, Sabi T, Kühl U, Lassner D, Schultheiss HP, Noutsias M.

Med Sci Monit. 2008 Dec;14(12):CR589-97.

PMID:
19043365
16.

Adaptive immune responses against parvovirus B19 in patients with myocardial disease.

Lindner J, Noutsias M, Lassner D, Wenzel J, Schultheiss HP, Kuehl U, Modrow S.

J Clin Virol. 2009 Jan;44(1):27-32. doi: 10.1016/j.jcv.2008.09.007. Epub 2008 Nov 5.

PMID:
18980860
17.

CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults.

Lindner J, Zehentmeier S, Franssila R, Barabas S, Schroeder J, Deml L, Modrow S.

J Infect Dis. 2008 Dec 1;198(11):1677-84. doi: 10.1086/592985.

PMID:
18831690
18.

Clinical and epidemiological aspects of human bocavirus infection.

Lindner J, Karalar L, Schimanski S, Pfister H, Struff W, Modrow S.

J Clin Virol. 2008 Dec;43(4):391-5. doi: 10.1016/j.jcv.2008.08.009. Epub 2008 Sep 26. Review.

PMID:
18823816
19.

Association of parvovirus B19 infection and Hashimoto's thyroiditis in children.

Lehmann HW, Lutterbüse N, Plentz A, Akkurt I, Albers N, Hauffa BP, Hiort O, Schoenau E, Modrow S.

Viral Immunol. 2008 Sep;21(3):379-83. doi: 10.1089/vim.2008.0001.

PMID:
18788945
20.

Human bocavirus--a novel parvovirus to infect humans.

Lindner J, Modrow S.

Intervirology. 2008;51(2):116-22. doi: 10.1159/000137411. Epub 2008 Jun 9. Review.

PMID:
18536522
21.

Generation of multifunctional murine monoclonal antibodies specifically directed to the VP1unique region protein of human parvovirus B19.

Drechsler MD, Obermeier I, Döring Y, Lackner KJ, Modrow S, von Landenberg P.

Immunobiology. 2008;213(6):511-7. doi: 10.1016/j.imbio.2007.12.003. Epub 2008 Jan 29.

PMID:
18514753
22.

Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Kaufmann B, Chipman PR, Kostyuchenko VA, Modrow S, Rossmann MG.

J Virol. 2008 Aug;82(15):7306-12. doi: 10.1128/JVI.00512-08. Epub 2008 May 28.

23.

Seroprevalence of parvovirus B19 in the German population.

Röhrer C, Gärtner B, Sauerbrei A, Böhm S, Hottenträger B, Raab U, Thierfelder W, Wutzler P, Modrow S.

Epidemiol Infect. 2008 Nov;136(11):1564-75. doi: 10.1017/S0950268807009958. Epub 2008 Jan 16.

24.

Are antiphospholipid antibodies an essential requirement for an effective immune response to infections?

von Landenberg P, Döring Y, Modrow S, Lackner KJ.

Ann N Y Acad Sci. 2007 Jun;1108:578-83. Review.

PMID:
17894022
25.

Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies.

Lehmann HW, Plentz A, von Landenberg P, Küster RM, Modrow S.

Clin Rheumatol. 2008 Mar;27(3):333-8. Epub 2007 Sep 13.

PMID:
17851708
26.

Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation.

Beske F, Modrow S, Sörensen J, Schmidt H, Kriener S, Allwinn R, Klingebiel T, Schwabe D, Lehrnbecher T.

Bone Marrow Transplant. 2007 Jul;40(1):89-91. Epub 2007 Apr 30. No abstract available.

PMID:
17468770
27.

Human parvovirus B19 infection and antiphospholipid antibodies.

von Landenberg P, Lehmann HW, Modrow S.

Autoimmun Rev. 2007 Apr;6(5):278-85. Epub 2006 Oct 13. Review.

PMID:
17412298
28.

"Contact voltage" in nanoparticle/molecule connections.

Modrow H, Modrow S, Hormes J, Waldöfner N, Bönnemann H.

J Phys Chem B. 2005 Jan 20;109(2):900-6.

PMID:
16866457
29.

Parvovirus B19: the causative agent of dilated cardiomyopathy or a harmless passenger of the human myocard?

Modrow S.

Ernst Schering Res Found Workshop. 2006;(55):63-82. Review.

PMID:
16329658
30.

CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.

Lindner J, Barabas S, Saar K, Altmann D, Pfister A, Fleck M, Deml L, Modrow S.

J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):356-61.

PMID:
16316401
31.

Human parvovirus B19 infection and antiphospholipid-syndrome: the two sides of one medal?

Landenberg P, Modrow S.

J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):353-5. Review. No abstract available.

PMID:
16316400
32.

Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.

Lowin T, Raab U, Schroeder J, Franssila R, Modrow S.

J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):348-52.

PMID:
16316399
33.

Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products.

Plentz A, Hahn J, Knöll A, Holler E, Jilg W, Modrow S.

Transfusion. 2005 Nov;45(11):1811-5.

PMID:
16271109
34.

T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.

Franssila R, Auramo J, Modrow S, Möbs M, Oker-Blom C, Käpylä P, Söderlund-Venermo M, Hedman K.

Clin Exp Immunol. 2005 Oct;142(1):53-61.

35.

Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.

Heinz C, Plentz A, Bauer D, Heiligenhaus A, Modrow S.

Graefes Arch Clin Exp Ophthalmol. 2005 Oct;243(10):999-1004. Epub 2005 Oct 20.

PMID:
15906067
36.

Parvovirus B19 does not bind to membrane-associated globoside in vitro.

Kaufmann B, Baxa U, Chipman PR, Rossmann MG, Modrow S, Seckler R.

Virology. 2005 Feb 5;332(1):189-98.

37.

Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S.

J Med Virol. 2005 Jan;75(1):161-9.

PMID:
15543575
38.

Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.

Plentz A, Hahn J, Holler E, Jilg W, Modrow S.

J Clin Virol. 2004 Sep;31(1):16-9.

PMID:
15288608
39.

The central domain of the matrix protein of HIV-1: influence on protein structure and virus infectivity.

Ellenrieder AD, Kremer W, Kattenbeck B, Hantschel O, Horn G, Kalbitzer HR, Modrow S.

Biol Chem. 2004 Mar-Apr;385(3-4):303-13.

PMID:
15134345
40.

Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies.

Lehmann HW, Plentz A, Von Landenberg P, Müller-Godeffroy E, Modrow S.

Arthritis Res Ther. 2004;6(1):R1-R6. Epub 2003 Oct 10.

41.

Parvovirus B19 infection and autoimmune disease.

Lehmann HW, von Landenberg P, Modrow S.

Autoimmun Rev. 2003 Jun;2(4):218-23. Review.

PMID:
12848949
42.

Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.

Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S.

Arthritis Rheum. 2003 Jul;48(7):1939-47.

43.

Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.

Lehmann HW, Knöll A, Küster RM, Modrow S.

Arthritis Rheum. 2003 Jun;48(6):1631-8.

44.

Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.

Lehmann HW, Kühner L, Beckenlehner K, Müller-Godeffroy E, Heide KG, Küster RM, Modrow S.

J Clin Virol. 2002 Aug;25(2):135-43.

PMID:
12367647
45.

Antibody responses in parvovirus B19 infected patients.

Modrow S, Dorsch S.

Pathol Biol (Paris). 2002 Jun;50(5):326-31. Review.

PMID:
12116851
46.

Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).

Knöll A, Louwen F, Kochanowski B, Plentz A, Stüssel J, Beckenlehner K, Jilg W, Modrow S.

J Med Virol. 2002 Jun;67(2):259-66.

PMID:
11992588
47.

NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3.

Raab U, Beckenlehner K, Lowin T, Niller HH, Doyle S, Modrow S.

Virology. 2002 Feb 1;293(1):86-93.

48.

The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.

Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, Modrow S.

J Virol. 2002 Feb;76(4):2014-8.

49.

Localization of the chaperone domain of FKBP52.

Pirkl F, Fischer E, Modrow S, Buchner J.

J Biol Chem. 2001 Oct 5;276(40):37034-41. Epub 2001 Jul 25.

50.

Cellular transcription factors that interact with p6 promoter elements of parvovirus B19.

Raab U, Bauer B, Gigler A, Beckenlehner K, Wolf H, Modrow S.

J Gen Virol. 2001 Jun;82(Pt 6):1473-80.

PMID:
11369893

Supplemental Content

Loading ...
Support Center